Thoracic reirradiation with SBRT for residual/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field-Reference-Cited by-同舟云学术

Thoracic reirradiation with SBRT for residual/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field

Published:2018-05 Issue:3 Volume:8 Page:e117-e123
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Horne Zachary D.,Dohopolski Michael J.,Clump David A.,Burton Steven A.,Heron Dwight E.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference33 articles.

1. American Cancer Society. Cancer Facts & Figures 2016. Atlanta, GA: American Cancer Society. Available at: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2016/. Accessed December 30, 2016.

2. The National Lung Screening Trial: Overview and study design;National Lung Screening Trial Research Team;Radiology,2011

3. Sequential vs concurrent chemoradiation for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst,2011

4. Recurrence patterns and second primary lung cancers after stereotactic body radiation therapy for early-stage non–small-cell lung cancer: Implications for surveillance;Spratt;Clin Lung Cancer,2016

5. Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone;Jeremic;J Clin Oncol,2001

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultra-Hypofractionated Re-Irradiation with Anti-PD-1 Immunotherapy for Locoregionally Recurrent (after Radical Chemo-Radiotherapy) Non-Small Cell Lung Cancer;Cancers;2023-10-20

2. The role of stereotactic body radiotherapy (SBRT) in the treatment of recurrent / progressive lung lesions after primary treatment;International Journal of Radiation Research;2023-10-01

3. Biological equivalent dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy;Radiotherapy and Oncology;2023-06

4. Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy;Radiation Oncology;2023-05-29

5. Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era;Frontiers in Oncology;2023-01-17